This inventor holds 2 USPTO granted patents. Top assignees: Carnegie Institution of Washington, University of Pennsylvania. Active years: 2009-2012.
Company Filing History:
2 out of 89 
2 out of 2,645 
Years Active: 2009-2012
Title: Marnie Halpern: Innovator in Genetic Screening
Introduction
Marnie Halpern is a distinguished inventor based in Pikesville, MD (US). She has made significant contributions to the field of genetic screening, particularly in lipid and cholesterol processing. With a total of 2 patents, her work has implications for understanding and treating metabolic disorders.
Latest Patents
Marnie Halpern's latest patents focus on high throughput genetic screening of lipid and cholesterol processing using fluorescent compounds. The first patent utilizes fluorescent lipids, particularly quenched phospholipid or cholesterol analogues, to facilitate screening for phenotypes representing perturbations of lipid and/or cholesterol processing in vertebrates. This invention also aids in screening for genetic mutations that lead to disorders of phospholipid and/or cholesterol metabolism, as well as compounds designed to treat these disorders. The second patent mirrors the first, emphasizing the importance of fluorescent lipids in screening for genetic mutations and treatment options.
Career Highlights
Throughout her career, Marnie has worked with prestigious institutions such as the University of Pennsylvania and the Carnegie Institution of Washington. Her innovative research has garnered attention and respect in the scientific community.
Collaborations
Marnie has collaborated with notable colleagues, including Michael Pack and Steven A. Farber. These partnerships have further enriched her research and contributions to the field.
Conclusion
Marnie Halpern's work in genetic screening represents a significant advancement in understanding lipid and cholesterol metabolism. Her patents and collaborations highlight her dedication to innovation in this critical area of research.